In the News

Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test

GRAIL has entered an agreement with Quest Diagnostics to provide phlebotomy services in support of its multi-cancer early detection blood test. The test, called Galleri, is expected to go to market in the second quarter after its PATHFINDER multi-site interventional study. Under the agreement, Quest’s phlebotomy network,...

Truveris Expands Leadership Team With Key Appointments

Truveris, a digital health company focused on reducing costs and improving access in pharmacy, announced that it has bolstered its leadership team with several key hires and internal appointments. Under the leadership of CEO Jeff Eberle, Truveris has assembled a seasoned team of industry veterans...